Germany · Delayed Price · Currency is EUR Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of EUR 90.39 million. The enterprise value is 14.88 million.
| Market Cap | 90.39M |
| Enterprise Value | 14.88M |
Important Dates
The next estimated earnings date is Friday, March 6, 2026.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 153.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +20.75% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 30.32% |
| Float | 134.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.97 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.17 |
Financial Position
The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.62 |
| Quick Ratio | 5.45 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.15 |
| Interest Coverage | -9,305.38 |
Financial Efficiency
Return on equity (ROE) is -71.73% and return on invested capital (ROIC) is -42.67%.
| Return on Equity (ROE) | -71.73% |
| Return on Assets (ROA) | -39.13% |
| Return on Invested Capital (ROIC) | -42.67% |
| Return on Capital Employed (ROCE) | -99.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -644,911 |
| Employee Count | 152 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.92% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 970 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -103.10M |
| Pretax Income | -98.03M |
| Net Income | -98.03M |
| EBITDA | -97.54M |
| EBIT | -103.10M |
| Earnings Per Share (EPS) | -1.07 |
Balance Sheet
The company has 87.87 million in cash and 13.24 million in debt, giving a net cash position of 74.63 million.
| Cash & Cash Equivalents | 87.87M |
| Total Debt | 13.24M |
| Net Cash | 74.63M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 93.02M |
| Book Value Per Share | 1.01 |
| Working Capital | 74.62M |
Cash Flow
In the last 12 months, operating cash flow was -83.90 million and capital expenditures -1.64 million, giving a free cash flow of -85.54 million.
| Operating Cash Flow | -83.90M |
| Capital Expenditures | -1.64M |
| Free Cash Flow | -85.54M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Adicet Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.75% |
| Shareholder Yield | -20.75% |
| Earnings Yield | -108.45% |
| FCF Yield | -94.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |